Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma
about
A central role for inducible heat-shock protein 70 in autoimmune vitiligoNew perspectives on the role of vitiligo in immune responses to melanomaHuman T cell crosstalk is induced by tumor membrane transferCombination immunotherapy for high-risk resected and metastatic melanoma patientsAutoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell helpImproved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapiesMultiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancerImmune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity.Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10.Immunomodulation of malignant melanoma by contact sensitizing agents.The delicate balance of melanoma immunotherapy.Challenges faced when identifying patients for combination immunotherapy.Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.Optimizing T-cell receptor gene therapy for hematologic malignancies.CD70 and Th17 are involved in human contact sensitivity.Resident memory T cells in the skin mediate durable immunity to melanoma.Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.
P2860
Q26823593-885809C8-9444-4A9B-9A08-AC871C1C53E0Q26996799-4D7CF3DD-B93E-424A-92A4-11967520E234Q27314569-FCC8732A-0BE9-4D60-9A77-7554B78AEAE0Q33737498-369C6734-820F-4ACF-A4CF-4E19E8E148BDQ33829513-B43FA858-E4F7-429F-81C1-21933CC3D7D1Q34064488-97093C56-C258-4754-90F3-E23AF66C1235Q34511672-B35687A2-7D63-4055-9A1B-E01587153894Q34637366-B000833E-D0F3-4AE8-9BE6-F287B2DE1FB0Q36487567-BD6E0AE3-0C1A-4C19-82C2-F481630ED3AFQ36586109-5BF31C57-40B1-4E28-A782-20D6FFB064C0Q36675055-6F9AA6B3-7D0C-48D7-8E73-2B62EB856032Q37088617-F4207428-DE01-4851-9591-3B066E8AF14DQ37492464-5C1E604E-AE82-4318-B2A6-45798EE29EDCQ37587225-1433FB93-6CD7-4391-B0C9-17F1558E5738Q38168949-60A18742-B076-4DFE-96AC-EDA86C28F42EQ38288116-93F966F0-CC7A-42B9-96FD-E74967245324Q38638046-96CD7C97-2B8F-4100-AC8E-0EB174BC1568Q38798375-226E02F6-7446-4093-8347-E9EB65F4ACB5Q38840466-5B35D041-68E4-4C4F-872D-24975DA6ACF8Q39701317-512748AD-65A1-409A-9AE6-F58F0B0C98F6Q40122403-419F1162-9142-4571-BFF9-5B2D32F04FEEQ42229717-7E42B3C8-0A16-4576-8904-E842159DE70F
P2860
Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@ast
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@en
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@nl
type
label
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@ast
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@en
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@nl
prefLabel
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@ast
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@en
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@nl
P2093
P2860
P356
P1476
Autoimmune melanocyte destruct ...... ll responses to mouse melanoma
@en
P2093
Anik L Côté
Edward J Usherwood
Katelyn T Byrne
Marc S Ernstoff
Mary Jo Turk
Peisheng Zhang
Rameeza Allie
Weijun Zhang
Yanxia Guo
P2860
P304
P356
10.1172/JCI44849
P407
P577
2011-04-11T00:00:00Z